A study to assess treatment in patient who diagnosed with alcohol withdrawal syndrome
Not Applicable
Completed
- Conditions
- Health Condition 1: F102- Alcohol dependence
- Registration Number
- CTRI/2021/12/038427
- Lead Sponsor
- Abbott Healthcare Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
1.Male/female of >= 18 years of age at the time of data collection.
2.Patient admitted with AWS Symptoms
3.Patient with at least 3 months documented follow ups
Exclusion Criteria
1.Patient was directly admitted to the ICU when alcohol withdrawal treatment was initiated.
2.Patient who had a positive urine toxicology screen for BZDs (unless given for the treatment of alcohol withdrawal), barbiturates, opiates (unless administered at URMC prior to sampling), or other illegal substances.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the treatment pattern of alcohol withdrawal patients during hospitalization, at discharge and follow upTimepoint: During hospitalisation and follow up (after discharge)
- Secondary Outcome Measures
Name Time Method To assess clinical and demographic profiles of patients with alcohol withdrawal syndromeTimepoint: Age, Gender, Height and weight, BMI, Occupation, Medical history, Family history of alcohol dependence/other psychiatric illness, Adequate history of type of alcohol <br/ ><br> <br/ ><br>Co-relate the choice of BZDs with LFT levels (ALT/AST/Bilirubin ) as available <br/ ><br> <br/ ><br>Adjunctive treatment used for Alcohol deaddiction <br/ ><br> <br/ ><br>Average duration of hospital stay <br/ ><br> <br/ ><br>Nonpharmacological treatment used during the treatment <br/ ><br>